“…Meanwhile, MPO, CD38, CD36, CD15, CD34, CD11b, and CD2 exhibited expression levels between 24.48 % and 45.06 %, with the remaining CD markers showing expression levels below 20 % in all cases. These findings were consistent with previous studies on AML ( Rasheed et al, 2021 , Piñero et al, 2022 ). Previous researchers noted that markers such as MPO, CD13, CD33, CD15, and CD117 are specific to myeloid cells, while CD11c, CD64, CD14, and CD36 indicate monocytic lineage.…”